· Net revenue for the third quarter increased to SEK 5.5 million (2.3) and for January-September to SEK 18.2 million (7.5)*
· The net loss for the third quarter totaled SEK 4.7 million (4.3) and for January-September SEK 13.2 million (16.6)
· Earnings per share for the third quarter amounted to SEK -0.08 (-0.07) and for January-September SEK -0.22 (-0.28)
· Sales of Artelon® Spacer for the third quarter increased to SEK 2.5 million (1.2) and for January-September to SEK 10.7 million (4.9)
· Sales of Artelon® Tissue Reinforcement for the third quarter increased to SEK 2.5 million (1.1) and for January-September to SEK 6.9 million (2.5)
· Emerging Medical Group was appointed as the new sales management team for Artimplant USA
N.B. This is a translation from Swedish. The Swedish version shall always take precedence.
